Investigation of the Effect of Ocrelizumab on Peripheral Lymphocyte Immunophenotypes with Suppressive Capacity in MS
Clinical trial NCT04874597 · UNKNOWN
Trial details
- NCT number
- NCT04874597
- Sponsor
- Dr Recai Turkoglu
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-11-15
- Primary completion
- 2025-04-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.